Compared to silencing other lipogenic genes, silencing SCD1 in breast cancer cells exerts the strongest inhibitory effect on cell proliferation and a weaker inhibitory effect on homologous nonmalignant epithelial cells [4, 5, 7, 8]. This evidence concerns the gene SCD and breast cancer.